Protagonist Therapeutics PTGX
NASDAQ PTGX
$138.43 -1.10 (-0.79%)
At close: Oct 23, 2026 · 4:00 PM EDT

Protagonist Therapeutics (PTGX) Gains from Investment Securities (2025)

Updated

Analysis

Protagonist Therapeutics (PTGX) Gains from Investment Securities (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Protagonist Therapeutics 8.95 Bn 6.48 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -5,000.00
API Access

Protagonist Therapeutics Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=PTGX&period=max&api_key=YOUR_API_KEY